Since 1991, Selectin Biosciences Inc. has provided glycobiology researchers and biopharmaceutical companies the most complete product line of recombinant and native glycoenzymes and kits. Selectin manufactures and markets, directly and through its authorized distributors, nearly eighty percent of world-wide demand for glycosidases and related enzymes. We developed the Enzymatic Deglycosylation Kit and the Sialic Acid Quantitation Kit, the two most popular kits among glycobiologists and cell biologists.

We were the first to clone and commercially produce some of the most useful glycosidases such as Endo-O-glycosidase and β-galactosidase (from
Streptococcus pneumonia) and neuraminidase (from Arthrobacter ureafaciens). We remain the only world-wide source of these and many other enzymes.

Selectin Biosciences Inc. is committed to continued innovation in the glycobiology field.